Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Stenting Strategies in Left Main Bifurcation
Author(s): Suryono Suryono , Muhammad Farhan Hibatulloh , Alfiyah Ramadhani , et al Added: 3 months ago

Intervention

Vascular Disease and Surgery
Stent Underexpansion and Aorto-ostial Lesions Management
Author(s): Luca Paolucci , Asad Shabbir , Marco Lombardi , et al Added: 1 year ago

Imaging & Diagnostics

Intervention
Ultimaster TANSEI in Complex Coronary Lesions
Author(s): Ricardo Palma-Carbajal , Yassin Belahnech , José M de la Torre Hernández , et al Added: 1 month ago

Intervention

MI/ACS
IVUS123 workflow for PCI
Author(s): Simon J Walsh , Rafael Cavalcante , Kevin Croce , et al Added: 3 months ago

Guidelines & Statements

Intervention
Added: 10 months ago Source:  Radcliffe Cardiology
AUTHOR: Greg GuilloryThe selection of drug-eluting stents (DES) for percutaneous coronary intervention (PCI) involves balancing efficacy against safety. The SORT OUT XI randomised trial aimed to compare a newer-generation biolimus-eluting stent with a contemporary dual-therapy sirolimus-eluting stent in a real-world patient population, providing crucial head-to-head evidence.¹SORT OUT XI was a… View more

Intervention

MI/ACS
CIRSE 25: The BIONETIC-I Study
Author(s): Marianne Brodmann Added: 8 months ago
CIRSE Congress 2025 - 24-month results show the Biotronik Dynetic-35 cobalt chromium balloon-expandable stent was safe and effective in iliac arteries.Prof Marianne Brodmann (Medical University of Graz, Graz, AT) joins us to discuss 24-month findings from BIONETIC-I (NCT04830228). The prospective, international, multi-center, single-arm study aimed to investigate the safety and effectiveness of… View more

Intervention

Vascular Disease and Surgery
EuroPCR 25: The DANAMI-3-DEFER Trial
Author(s): Jacob Thomsen Lønborg Added: 12 months ago
EuroPCR 25 - 10-year follow-up findings of DANAMI-3-DEFER show a deferred stenting strategy may reduce HF hospitalisation in ST-elevation myocardial infarction (STEMI) patients.We are joined by Dr Jacob Lønborg (Rigshospitalet, Copenhagen, DK) to discuss key findings from the 10-year follow-up of the DANAMI-3-DEFER (NCT01435408) trial. This randomized controlled trial compared deferred stent… View more

Intervention

MI/ACS
CREST-2: Stenting Benefits Asymptomatic Carotid Stenosis
Added: 3 months ago Source:  Radcliffe Vascular
The optimal management for asymptomatic carotid stenosis has been a subject of debate, particularly with advancements in medical therapy. New findings from the Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) provide clarity, suggesting a benefit for carotid-artery stenting when added to intensive medical management.¹MethodologyCREST-2 involved… View more

Intervention

Prevention & Chronic Conditions
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
Added: 3 months ago Source:  Radcliffe Vascular
The optimal management for patients with high-grade asymptomatic carotid stenosis remains a key clinical question, particularly with advancements in medical therapy and revascularisation techniques. The CREST-2 trials were designed to assess whether adding revascularisation to intensive medical management provides a greater benefit than intensive medical management alone in this patient… View more

Guidelines & Statements

Intervention
EuroPCR 24: The ABILITY Study
Author(s): Roxana Mehran Added: 1 year ago
EuroPCR 24 - Dr Roxana Mehran (Mount Sinai Hospital, US) outlines the findings of the ABILITY Global Diabetes study onsite at EuroPCR 2024.The ABILITY study (NCT04236609) aimed to evaluate the efficacy and safety of the Abluminus DES+ Sirolimus Eluting Stent System (SES) as compared to the XIENCE Everolimus Eluting Coronary Stent System in diabetic patients eligible for percutaneous coronary… View more

Intervention